Navigation Links
Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology

mbolytic, anti-ischemic and anti-angiogenic proprieties, suppressed in vitro both the expression of heparanase gene and heparanase enzymatic activity in multiple myeloma tumor cell lines. Consequently, this study addressed Defibrotide's effectiveness to regulate the expression and activity of heparanase in human microvascular endothelial cell (HMEC) and rat kidney epithelial cell lines (NRK52E) grown in hyperglycemia conditions.

About Gentium

Gentium, S.p.A., located in Como, Italy, is a biopharmaceutical company focused on the research, discovery and development of drugs to treat and prevent a variety of vascular diseases and conditions related to cancer and cancer treatments. Defibrotide, the Company's lead product candidate, is an investigational drug that has been granted Orphan Drug status and Fast Track Designation by the U.S. Food and Drug Administration to treat Severe Veno-occlusive disease (VOD) and Orphan Medicinal Product Designation by the European Commission both to treat and to prevent VOD.

Cautionary Note Regarding Forward-Looking Statements

This press release contains "forward-looking statements." In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of these terms and other comparable terminology. These statements are not historical facts but instead represent the Company's belief regarding future results, many of which, by their nature, are inherently uncertain and outside the Company's control. It is possible that actual results may differ, possibly materially, from those anticipated in these forward-looking statements. For a discussion of some of the risks and important factors that could affect future results, see the discussion in our Form 20-F for the year ended December 31, 2005 under the caption "Risk Factors."

Source: Gentium

Contact
'"/>




Page: 1 2 3

Related medicine technology :

1. Gentiums Defibrotide Seen as Active in Multiple Myeloma
2. Gentiums Defibrotide Highlighted in Two Poster Presentations at American Association for Cancer Research Annual Meeting
3. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
4. Isotechnikas Lead Drug, ISA247, To Be Highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
5. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
6. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
7. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
8. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
9. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress
Post Your Comments:
(Date:11/22/2014)... , 21 de noviembre de 2014  BioClinica®, ... clínicos externalizados y tecnologías eClinical, ha indicado un ... ,seguimiento inteligente, para el seguimiento basado en el ... amplía el concepto del seguimiento basado en el ... las visitas de seguimiento o cambio de los ...
(Date:11/22/2014)... Statistics released from a number of organizations show that ... holidays, beginning with Thanksgiving eve, which is now termed ... data, highlighted in an Infographic released by ... annual Sober Days for the Holidays public awareness ... increased rates of DUI injuries and deaths during the ...
(Date:11/22/2014)... 2014  Particle Sciences, Inc (PSI), the leading ... manufactured a new innovative vaginal ring for Ladee ... arm of Exeltis Pharmaceuticals.  According to Bruce ... Particle Sciences, "This vaginal ring was developed for ... and modeling expertise.  We are thrilled it is ...
Breaking Medicine Technology:El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3Alarming Stats Show Holiday Drinking an Issue for Many 2Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2
... Time - SOUTH SAN FRANCISCO, Calif., March 16 ... biopharmaceutical company focused on oncology, today reported financial results ... 2008, and provided a corporate update. "During the fourth ... goal of developing picoplatin as an oncology platform compound ...
... announced that it has initiated a Phase II clinical ... ulcers. HP802-247 is a topical spray containing living keratinocytes ... effectiveness of two cell concentrations and two dosing frequencies ... placebo plus standard care, in healing venous leg ulcers ...
Cached Medicine Technology:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 7Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 8Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 9Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers 2Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers 3
(Date:11/22/2014)... 22, 2014 Forbes Living TV ... pleased to announce that Ashley Lombardo and friend Candy ... , Ms. Lombardo entered friend Candy Sherman to ... wrote of how her friend is courageously battling lung ... single mom. Despite medical bills piling up and the ...
(Date:11/22/2014)... November 22, 2014 Developers and plugin specialist ... plugin entitled FCPX 3D Model bringing the impossible to ... allows users to add obj files to FCPX enabling 3d ... “Blurring the line between professional and armature, FCPX 3D Model ... Film Studios allows Final Cut Pro X users to upload ...
(Date:11/22/2014)... News) -- A clinical trial of hydroxyurea therapy for ... year early because the results show it is a ... reduce the risk of stroke. The announcement about ... in the United States and Canada, was made this ... Institute (NHLBI). Researchers compared monthly blood transfusions with ...
(Date:11/22/2014)... widely used heart drug digoxin is associated with increased ... the heart rhythm disorder atrial fibrillation but no evidence ... fibrillation is a common form of irregular heartbeat that ... stroke among older Americans. Digoxin has been used for ... the authors of the new study said, and many ...
(Date:11/21/2014)... 21, 2014 Body Well Therapy, a leading ... accepts Spafinder massage gift cards and gift ... massage in all service areas including throughout Florida and the ... go to the spa at all to redeem your Spafinder ... Body Well. "We may not be able to transport all ...
Breaking Medicine News(10 mins):Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3Health News:Body Well Mobile Massage Announces Acceptance of Spafinder Gift Cards for In Home Massage, Hotel Massage for Travelers 2
... The following is a,statement of William V. ... Bush today let down America,s children and protected ... that would,increase the federal cigarette tax by 61 ... Health Insurance Program (SCHIP). The President has missed,an ...
... LARGO, Fla. and RIDGEFIELD, Conn., Oct. 3 ,Unilens Vision ... Eschenbach Optik announced today that Eschenbach Optik has been ... Lens.,Eschenbach Optik of America, Inc. will serve as the ... GmbH + Co will be the,exclusive distributor in the ...
... Comments on Company,s Restructuring, Recovery and Revitalization, ... of,PainCare Holdings, Inc. (Amex: PRZ ), one ... surgical solutions and services, today issued,the following corporate ... impact and support the Company,s refined long term,growth ...
... Free Patient Education Campaign Urges Enrollment, LOS ANGELES, ... a,significant number of clinical trials are being conducted to ... chronic and potentially fatal,autoimmune disease that affects more than ... A key question that clinical trials answer is, ...
... ... Workplace, Company Develops Community Educational Partnership with St. Joseph Health ... System in Orange County, IRVINE, Calif., ... in the United States, has opened 14 health care,centers at CVS/pharmacy stores in Los ...
... issued,today by the American Heart Association/American Stroke Association: ... offers,solutions The American Heart Association/American Stroke Association ... identify disparities,in healthcare and help patients get the ... published in the Oct. 3 issue of the ...
Cached Medicine News:Health News:President's Veto of Bill to Increase Cigarette Tax, Fund SCHIP Benefits Big Tobacco at Expense of America's Kids 2Health News:Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens 2Health News:Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens 3Health News:PainCare Reports on Key Corporate Developments 2Health News:PainCare Reports on Key Corporate Developments 3Health News:PainCare Reports on Key Corporate Developments 4Health News:PainCare Reports on Key Corporate Developments 5Health News:Clinical Trials for Lupus Underway After Decades of Drought 2Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Los Angeles Metro Area 2Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Los Angeles Metro Area 3Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Los Angeles Metro Area 4Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Los Angeles Metro Area 5Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Los Angeles Metro Area 6Health News:News From the American Heart Association/American Stroke Association 2Health News:News From the American Heart Association/American Stroke Association 3Health News:News From the American Heart Association/American Stroke Association 4Health News:News From the American Heart Association/American Stroke Association 5Health News:News From the American Heart Association/American Stroke Association 6
... The dual-electrode SPL defibrillator ... electrode design, offering the flexibility ... lead. Designed for the physician ... two shocking coils, the SPL ...
The Livewire cannulator offers improved access to the coronary sinus by combining the ergonomic Livewire steering mechanism with numerous specialized features....
... Stockert 70 RF Generator introduces ... lab every day, in every ... 70 and the CARTO EP ... Ablation Catheter provide clinicians with ...
... The Integrity family of pacemakers ... advanced and truly automatic devices ... Offering an unparalleled combination of ... the system builds on the ...
Medicine Products: